Clorox (CLX) Dividend Stock Analysis

Published on

The Clorox Co (NYSE:CLX) manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International.

Get The Full Series in PDF

Get the entire 10-part series on Charlie Munger in PDF. Save it to your desktop, read it on your tablet, or email to your colleagues.

Q1 2021 hedge fund letters, conferences and more

Clorox's Annual Dividend Increases

Clorox is a dividend aristocrat with a 44-year history of annual dividend increases. Over the past decade, Clorox has managed to increase dividends at an annualized rate of 7.50%.

The last dividend increase was in June 2021, when the Board of Directors authorized a 4.50% hike in the quarterly dividend to $1.16/share.

Clorox

The company managed to grow earnings from $4.24/share in 2010 to $7.36/share in 2020. Clorox is expected to earn $8.38/share in 2021 and $8.13/share in 2022. The Covid-19 pandemic increased demand for Clorox products in the near term. While it is possible that growth in the near term would decelerate because people are not stocking up, it is also possible that we are in a new normal that would permanently increase the demand for its products.

Clorox

It is fascinating how earnings per share basically remained flat between 2010 and 2015, which tested the patience of most long-term shareholders.

Clorox has a portfolio of products with strong brand names, that are number one or two in their respective product lines, which helps in having pricing power. As a result, it should be able to pass on commodity price increases to customers. Future earnings growth could be driven by innovation, new product launches, cost containment initiatives, as well as international expansion.

Delivering Returns

Clorox aims to continue delivering total stockholder returns by focusing on company's long-term financial goals such as:

  • Growing net sales 2-4 percent annually
  • Expanding earnings before interest and income taxes (EBIT) margin 25-50 basis points annually
  • Generating free cash flow of 11- 13 percent of sales annually

The three pillars of the strategy include expansion in a geographic, category and channel direction, continued reinvestment in its brands as well as cost containment initiatives. A key driver of the strategy is to accelerate sales by growing existing brands, including expanding into adjacent categories, entering new sales channels and increasing penetration within existing countries. Increased exposure to emerging market economies could further drive increase in sales. The company also anticipates using its strong cash flow to pursue growth opportunities and increase shareholder returns. In addition to that the company will be targeting sales growth through product innovation, which helps its pricing power.

Clorox will also target margin expansion and maximizing cash flow through implementation a continued robust cost-saving program and maintaining price increases the company has taken. The strong focus on cost, has provided the company with a relative cost advantage versus competition. In addition, Clorox continuously reinvests money in its brands, which helps it maintain its market position.

One of the risks behind Clorox is that it generates a large portion of revenues from the US – over 80%. It is more exposed to the US economy than other global consumer staples companies, which could also be an opportunity as well. The other risk I see is that Wal-Mart (WMT) accounts for a quarter of sales for Clorox. Wal-Mart is notorious for trying to keep costs low, by squeezing vendors to sell at lower prices. This is bad for pricing power, and could impact profitability. This over reliance on Wal-Mart could be mitigated through continued international expansion. The other risk include competition from generic products, which could be mitigated by the ability to distinguish Clorox' brands by spending on R&D and advertising.

IGNITE Strategy

In 2019, the Company unveiled its “IGNITE” strategy, which works on top of its concluded 2020 strategy. Source: Clorox PR

Growth in earnings per share was aided by a gradual decrease in the number of shares outstanding. Clorox has reduced its share count from 141 million in 2010 to 128 million by 2020.

Clorox

The dividend payout ratio increased from 47% in 2010 to 67.73% in 2015, before falling down to 58% in 2020.

Clorox

Currently the stock is slightly overvalued at 23.23 times forward earnings. Clorox yields 2.59%.

Relevant Articles:

Article by Dividend Growth Investor

Clorox Co (CLX) Dividend Stock Analysis

Updated on

The Clorox Company (CLX) manufactures and markets consumer and professional products worldwide. It operates in four segments – Cleaning, Household, Lifestyle and International. This dividend aristocrat has paid dividends since 1968 and has increased them each year since 1977.

Get The Timeless Reading eBook in PDF

Get the entire 10-part series on Timeless Reading in PDF. Save it to your desktop, read it on your tablet, or email to your colleagues.

Check out our H2 hedge fund letters here.

Last month, Clorox hiked its dividend by 14% to 96 cents/share. This was an accelerated declaration of the company's dividend increase, which typically takes place in the month of May.

Over the past decade this dividend growth stock has delivered an annualized total return of 11.70% to its shareholders.

Clorox Co (CLX)

The company has managed to deliver a 5.20% average increase in annual EPS over the past decade. Clorox is expected to earn $6.13 per share in 2018 and $6.51 per share in 2019. In comparison, the company earned $5.35/share in 2017.

clost

In addition, between 2008 and 2017, the number of shares decreased from 142 million to 132 million.

Clorox has a portfolio of products with strong brand names, that are number one or two in their respective product lines, which helps in having pricing power. As a result, it should be able to pass on commodity price increases to customers. Future earnings growth could be driven by innovation, new product launches, cost containment initiatives, as well as international expansion.

Clorox aims to continue delivering total stockholder returns by focusing on company's long-term financial goals such as:

• Growing net sales 3-5 percent annually

• Expanding earnings before interest and income taxes (EBIT) margin 25-50 basis points annually

• Generating free cash flow of 10 percent to 12 percent of sales annually

The three pillars of the strategy include expansion in a geographic, category and channel direction, continued reinvestment in its brands as well as cost containment initiatives. A key driver of the strategy is to accelerate sales by growing existing brands, including expanding into adjacent categories, entering new sales channels and increasing penetration within existing countries. Increased exposure to emerging market economies could further drive increase in sales. The company also anticipates using its strong cash flow to pursue growth opportunities and increase shareholder returns. In addition to that the company will be targeting sales growth through product innovation, which helps its pricing power. Clorox will also target margin expansion and maximizing cash flow through implementation a continued robust cost-saving program and maintaining price increases the company has taken. The strong focus on cost, has provided the company with a relative cost advantage versus competition. In addition, Clorox continuously reinvests money in its brands, which helps it maintain its market position.

One of the risks behind Clorox is that it generates a large portion of revenues from the US – over 80%. It is more exposed to the US economy than other global consumer staples companies, which could also be an opportunity as well. The other risk I see is that Wal-Mart (WMT) accounts for a quarter of sales for Clorox. Wal-Mart is notorious for trying to keep costs low, by squeezing vendors to sell at lower prices. This is bad for pricing power, and could impact profitability. This over reliance on Wal-Mart could be mitigated through continued international expansion. The other risk include competition from generic products, which could be mitigated by the ability to distinguish Clorox' brands by spending on R&D and advertising.

The annual dividend payment has increased by 8% per year over the past decade, which is higher than the growth in EPS. This was accomplished through the expansion of the dividend payout ratio. Future growth will be limited by any growth in earnings per share. The five year growth in annual dividends of 5.80% is closer to what we can reasonably expect going forward from Clorox in terms of future dividend growth.

clost

An 8% growth in distributions translates into the dividend payment doubling every nine years on average. Since 1986, Clorox has been able to double dividends almost every seven years on average.

The dividend payout ratio increased from 51% in 2008 to almost 60.60% in 2017. A lower payout is always a plus, since it leaves room for consistent dividend growth minimizing the impact of short-term fluctuations in earnings.

clost

The company’s Return on Assets has decreased slightly over the past decade. Rather than focus on absolute values for this indicator, I generally want to see at least a stable return over time.

Currently, the stock is slightly overvalued at 21.20 times forward earnings. The stock yields 2.90% today. I am analyzing the company because I believe it is quality dividend growth stock, which may be worth a second look on dips below $122/share. This is equivalent to a forward P/E below 20. For more conservative investors, they may want to wait for 20 times FY 2017 earnings, which is the equivalent of buy the dip below $107/share.

Relevant Articles:

Article by Dividend Growth Investor

Leave a Comment